These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 20850313

  • 1. Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.
    Lee J, Bae S, Lee SH, Choi H, Kim YH, Kim SJ, Park GT, Moon SK, Kim DH, Lee S, Ahn SK, Choi NS, Lee KJ.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6327-30. PubMed ID: 20850313
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.
    Marathe PH, Kamath AV, Zhang Y, D'Arienzo C, Bhide R, Fargnoli J.
    Cancer Chemother Pharmacol; 2009 Dec 01; 65(1):55-66. PubMed ID: 19396600
    [Abstract] [Full Text] [Related]

  • 4. 1-Phenyl-dihydrobenzoindazoles as novel colchicine site inhibitors: Structural basis and antitumor efficacy.
    Jiang J, Zhang H, Wang C, Zhang Q, Fang S, Zhou R, Hu J, Zhu J, Zhou Y, Luo C, Zheng C.
    Eur J Med Chem; 2019 Sep 01; 177():448-456. PubMed ID: 31174062
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of phenstatin metabolites.
    Ghinet A, Rigo B, Hénichart JP, Le Broc-Ryckewaert D, Pommery J, Pommery N, Thuru X, Quesnel B, Gautret P.
    Bioorg Med Chem; 2011 Oct 15; 19(20):6042-54. PubMed ID: 21920767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone.
    Magalhães HI, Bezerra DP, Cavalcanti BC, Wilke DV, Rotta R, de Lima DP, Beatriz A, Alves AP, Bitencourt Fda S, de Figueiredo IS, Alencar NM, Costa-Lotufo LV, Moraes MO, Pessoa C.
    Cancer Chemother Pharmacol; 2011 Jul 15; 68(1):45-52. PubMed ID: 20821328
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents.
    Liu J, Zheng CH, Ren XH, Zhou F, Li W, Zhu J, Lv JG, Zhou YJ.
    J Med Chem; 2012 Jun 28; 55(12):5720-33. PubMed ID: 22676247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
    Gurjar MK, Wakharkar RD, Singh AT, Jaggi M, Borate HB, Shinde PD, Verma R, Rajendran P, Dutt S, Singh G, Sanna VK, Singh MK, Srivastava SK, Mahajan VA, Jadhav VH, Dutta K, Krishnan K, Chaudhary A, Agarwal SK, Mukherjee R, Burman AC.
    J Med Chem; 2007 Apr 19; 50(8):1744-53. PubMed ID: 17373779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D, Nudelman A, Tarasenko N, Levovich I, Makarovsky I, Sochotnikov S, Tarasenko I, Rephaeli A.
    J Med Chem; 2008 Jan 24; 51(2):314-23. PubMed ID: 18163551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
    Zhang HZ, Crogan-Grundy C, May C, Drewe J, Tseng B, Cai SX.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2852-8. PubMed ID: 19282188
    [Abstract] [Full Text] [Related]

  • 18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
    Popowycz F, Schneider C, Debonis S, Skoufias DA, Kozielski F, Galmarini CM, Joseph B.
    Bioorg Med Chem; 2009 May 01; 17(9):3471-8. PubMed ID: 19349183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.